BRIEF published on 11/22/2024 at 13:35, 10 hours 36 minutes ago American Battery Materials Secures Authorization for Exploration in Utah Renewable Energy Critical Minerals Lithium Exploration Environmental Responsibility Utah Approvals
PRESS RELEASE published on 11/22/2024 at 13:30, 10 hours 41 minutes ago American Battery Materials Receives Approvals to Reenter Exploration Well in Utah American Battery Materials, Inc. receives agency approvals to reenter Peterson Fed 88-21P well bore in Utah for lithium extraction, supporting USA's critical minerals demand Renewable Energy Critical Minerals Lithium Extraction American Battery Materials Environmentally Responsible
Published on 11/22/2024 at 23:55, 16 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 41 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 1 hour 6 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 1 hour 41 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 5 hours 57 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 6 hours 18 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 7 hours 16 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 8 hours 11 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 1 day 17 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 4 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 6 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 6 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
